Cyclophosphamide inhibits the progression of Meniere's disease by reducing the generation of circulating immune complex

Zhang,Shu; Gong,Yulin; Liang,Yu; Wang,Boqian; Gao,Wei; Xu,Qianyun

doi:10.3892/etm.2021.10611

Cyclophosphamide inhibits the progression of Meniere's disease by reducing the generation of circulating immune complex

Authors:
- Shu Zhang
- Yulin Gong
- Yu Liang
- Boqian Wang
- Wei Gao
- Qianyun Xu
View Affiliations

Affiliations: Department of Otolaryngology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010110, P.R. China, Department of Rheumatology and Immunology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010110, P.R. China, Department of Computer Information and Network Management Center, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010110, P.R. China
Published online on: August 13, 2021 https://doi.org/10.3892/etm.2021.10611
Article Number: 1177
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endolymphatic hydrops is a characteristic pathological manifestation of Meniere's disease (MD) that has been previously associated with autoimmunity. Interest in the circulating immune complex (CIC) has increased due to its reported role in the occurrence of MD. The present study aimed to investigate the potential value of serum CIC concentration in the diagnosis of MD and the therapeutic potential of cyclophosphamide (CTX) for the treatment of MD. In the present study, guinea pigs were immunized with isologous crude inner ear antigens to establish an autoimmune MD model. Pure tone audiometry, Vestibular‑evoked myogenic potential test, electrocochleography test and auditory brainstem response was applied in this study for assessing the severity of MD in guinea pigs. ELISA was applied to measure CIC, tumor necrosis factor α (TNF‑α) and heat shock protein 70 (HSP70) expression levels in the serum samples of different groups of patients. Western blotting was applied to detect the protein expression of HSP70 in inner ear tissues in guinea pigs. Hematoxylin and eosin staining was applied to visualize the spiral ganglions in spiral ganglions models. CIC expression in the inner ear was detected by immunohistochemistry. In vivo experiments were performed to confirm the therapeutic effects of CTX in MD. Serum concentrations of CIC, TNF‑α and HSP70 were found to be significantly higher in patients with MD, which were also associated with increases in hearing classification and the severity of endolymphatic hydrops. Using a guinea pig MD model, ELISA results revealed significantly increased serum CIC, TNF‑α and HSP70 concentrations compared with those in the control group. ABR results showed that the thresholds in the CTX group were notably decreased compared with that in the dexamethasone group, whereas CIC concentrations in the serum were reduced following dexamethasone and CTX treatments compared with those after saline treatment. In the inner ear tissues, the CIC concentration in CTX group was lower than that in the dexamethasone group. Similarly, reductions in HSP70 and TNF‑α concentrations was also observed in a similar manner. Immunohistochemistry staining found notably lower CIC deposition in the inner ear tissues following CTX treatment than that in dexamethasone group. Taken together, higher CIC expression can be used as a biomarker for MD diagnosis. The efficacy of CTX in MD was found to be higher compared with that in dexamethasone, which may be associated with the effective inhibition of CIC, HSP70 and TNF‑α generation.

View Figures

View References

1	Anft D, Jamali Y, Scholz G and Mrowinski D: Electrocochleography and phase audiometry in diagnosis of Meniere disease. HNO. 49:102–108. 2001.PubMed/NCBI View Article : Google Scholar : (In German).
2	Sun Y, Zhang D, Sun G, Lv Y, Li Y, Li X, Song Y, Li J, Fan Z and Wang H: RNA-sequencing study of peripheral blood mononuclear cells in sporadic Meniere's disease patients: Possible contribution of immunologic dysfunction to the development of this disorder. Clin Exp Immunol. 192:33–45. 2018.PubMed/NCBI View Article : Google Scholar
3	Pai I, Mendis S, Murdin L, Touska P and Connor S: Magnetic resonance imaging of Meniere's disease: Early clinical experience in a UK centre. J Laryngol Otol. 134:302–310. 2020.PubMed/NCBI View Article : Google Scholar
4	Hallpike CS and Cairns H: Observations on the pathology of Meniere's syndrome: (Section of otology). Proc R Soc Med. 31:1317–1336. 1938.PubMed/NCBI
5	Caulley L, Quimby A, Karsh J, Ahrari A, Tse D and Kontorinis G: Autoimmune arthritis in Meniere's disease: A systematic review of the literature. Semin Arthritis Rheum. 48:141–147. 2018.PubMed/NCBI View Article : Google Scholar
6	Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF and de Vincentiis M: Meniere's disease might be an autoimmune condition? Autoimmun Rev. 11:731–738. 2012.PubMed/NCBI View Article : Google Scholar
7	Cooper MW and Kaylie DM: Is endolymphatic sac surgery beneficial for Meniere's disease? Laryngoscope. 130:2738–2739. 2020.PubMed/NCBI View Article : Google Scholar
8	Mathews J, Rao S and Kumar BN: Autoimmune sensorineural hearing loss: Is it still a clinical diagnosis? J Laryngol Otol. 117:212–214. 2003.PubMed/NCBI View Article : Google Scholar
9	Dornhoffer JL, Waner M, Arenberg IK and Montague D: Immunoperoxidase study of the endolymphatic sac in Meniere's disease. Laryngoscope. 103:1027–1034. 1993.PubMed/NCBI View Article : Google Scholar
10	Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, Perez-Garrigues H, Gonzalez-Oller C, Acosta L and Lopez-Escamez JA: High prevalence of systemic autoimmune diseases in patients with Meniere's disease. PLoS One. 6(e26759)2011.PubMed/NCBI View Article : Google Scholar
11	Harada T, Matsunaga T, Hong K and Inoue K: Endolymphatic hydrops and III type allergic reaction. Acta Otolaryngol. 97:450–459. 1984.PubMed/NCBI View Article : Google Scholar
12	Lopez-Escamez JA, Saenz-Lopez P, Gazquez I, Moreno A, Gonzalez-Oller C, Soto-Varela A, Santos S, Aran I, Perez-Garrigues H, Ibañez A and Lopez-Nevot MA: Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Meniere's disease: A case-control study. BMC Med Genet. 12(2)2011.PubMed/NCBI View Article : Google Scholar
13	Derebery MJ, Rao VS, Siglock TJ, Linthicum FH and Nelson RA: Meniere's disease: An immune complex-mediated illness? Laryngoscope. 101:225–229. 1991.PubMed/NCBI View Article : Google Scholar
14	Hsu L, Zhu XN and Zhao YS: Immunoglobulin E and circulating immune complexes in endolymphatic hydrops. Ann Otol Rhinol Laryngol. 99:535–538. 1990.PubMed/NCBI View Article : Google Scholar
15	Kim SH, Kim JY, Lee HJ, Gi M, Kim BG and Choi JY: Autoimmunity as a candidate for the etiopathogenesis of Meniere's disease: Detection of autoimmune reactions and diagnostic biomarker candidate. PLoS One. 9(e111039)2014.PubMed/NCBI View Article : Google Scholar
16	Zheng N and Lu Y: Targeting the IL-9 pathway in cancer immunotherapy. Hum Vaccin Immunother. 16:2333–2340. 2020.PubMed/NCBI View Article : Google Scholar
17	Oh S, Lee JH, Kwack K and Choi SW: Natural killer cell therapy: A new treatment paradigm for solid tumors. Cancers (Basel). 11(1534)2019.PubMed/NCBI View Article : Google Scholar
18	Derebery MJ and Berliner KI: Allergy and its relation to Meniere's disease. Otolaryngol Clin North Am. 43:1047–1058. 2010.PubMed/NCBI View Article : Google Scholar
19	Di Berardino F and Zanetti D: Delayed immunomodulatory effect of cow milk-free diet in Meniere's Disease. J Am Coll Nutr. 37:149–153. 2018.PubMed/NCBI View Article : Google Scholar
20	Kim J and Chan JJ: Cyclophosphamide in dermatology. Australas J Dermatol. 58:5–17. 2017.PubMed/NCBI View Article : Google Scholar
21	Berd D, Mastrangelo MJ, Engstrom PF, Paul A and Maguire H: Augmentation of the human immune response by cyclophosphamide. Cancer Res. 42:4862–4866. 1982.PubMed/NCBI
22	Emadi A, Jones RJ and Brodsky RA: Cyclophosphamide and cancer: Golden anniversary. Nat Rev Clin Oncol. 6:638–647. 2009.PubMed/NCBI View Article : Google Scholar
23	Tsuchida Y, Harada M, Shoda H, Goto A, Suzuki N, Murashima A, Osuga Y and Fujio K: Fertility preservation in patients receiving gonadotoxic therapies for systemic autoimmune diseases in Japan. Mod Rheumatol: Jan 18, 2021 (Epub ahead of print). doi: 10.1080/14397595.2020.1856020.
24	Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery and Society of Otorhinolaryngology Head and Neck Surgery Chinese Medical Association. Guideline of diagnosis and treatment of Meniere disease (2017). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 52:167–172. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
25	Kim DY, Kwon J, Kim JY, Cha HS, Kim YW, Kim IY and Im CH: New method for pure-tone audiometry using electrooculogram: A proof-of-concept study. Sensors (Basel). 18(3651)2018.PubMed/NCBI View Article : Google Scholar
26	Nakashima T, Naganawa S, Pyykko I, Gibson WP, Sone M, Nakata S and Teranishi M: Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl. 560:5–8. 2009.PubMed/NCBI View Article : Google Scholar
27	Welgampola MS and Colebatch JG: Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology. 64:1682–1688. 2005.PubMed/NCBI View Article : Google Scholar
28	Lu L, Tan CQ, Cui YG, Ding GP, Ju XB, Li YJ and Cai WJ: Analysis of the main components of inner ear antigens inducing autoimmune Meniere's disease in guinea pigs. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 43:596–600. 2008.PubMed/NCBI(In Chinese).
29	Perry M: Revised australian code of practice for the care and use of animals for scientific purposes. Aust Vet J. 76(286)1998.PubMed/NCBI View Article : Google Scholar
30	Kraaij T, Nilsson SC, van Kooten C, Okroj M, Blom AM and Teng YO: Measuring plasma C4D to monitor immune complexes in lupus nephritis. Lupus Sci Med. 6(e000326)2019.PubMed/NCBI View Article : Google Scholar
31	Gupta S, Lau K, Harding CO, Shepherd G, Boyer R, Atkinson JP, Knight V, Olbertz J, Larimore K, Gu Z, et al: Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 37:366–373. 2018.PubMed/NCBI View Article : Google Scholar
32	Wright T: Meniere's disease. BMJ Clin Evid. 2015(0505)2015.PubMed/NCBI
33	Young YH, Wu CC and Wu CH: Augmentation of vestibular evoked myogenic potentials: An indication for distended saccular hydrops. Laryngoscope. 112:509–512. 2002.PubMed/NCBI View Article : Google Scholar
34	Mao Z, Liu L, Peng L, Zhou L and Liu A: Electrocochleography in the diagnosis of Meniere's disease. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 28:964–967. 2014.PubMed/NCBI(In Chinese).
35	Hornibrook J: Tone burst electrocochleography for the diagnosis of clinically certain Meniere's disease. Front Neurosci. 11(301)2017.PubMed/NCBI View Article : Google Scholar
36	Helling K, Schonfeld U and Clarke AH: Treatment of Meniere's disease by low-dosage intratympanic gentamicin application: Effect on otolith function. Laryngoscope. 117:2244–2250. 2007.PubMed/NCBI View Article : Google Scholar
37	Gurkov R, Flatz W, Louza J, Strupp M, Ertl-Wagner B and Krause E: In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Meniere's disease. Otol Neurotol. 33:1040–1045. 2012.PubMed/NCBI View Article : Google Scholar
38	Tamai S: Physiological and pathological aspects of circulating immune complex. Nihon Rinsho. 68 (Suppl 6):S105–S109. 2010.PubMed/NCBI(In Japanese).
39	Salvidio G and Andres G: Immune deposits and immune complex disease. Clin Exp Rheumatol. 4:281–288. 1986.PubMed/NCBI
40	Savastano M, Giacomelli L and Marioni G: Non-specific immunological determinations in Meniere's disease: Any role in clinical practice? Eur Arch Otorhinolaryngol. 264:15–19. 2007.PubMed/NCBI View Article : Google Scholar
41	Matsuoka H, Kwon SS, Yazawa Y, Barbieri M and Yoo TJ: Induction of endolymphatic hydrops by directly infused monoclonal antibody against type II collagen CB11 peptide. Ann Otol Rhinol Laryngol. 111:587–592. 2002.PubMed/NCBI View Article : Google Scholar
42	Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M and Canis M: Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One. 7(e39086)2012.PubMed/NCBI View Article : Google Scholar
43	Bodmer D, Morong S, Stewart C, Alexander A, Chen JM and Nedzelski JM: Long-term vertigo control in patients after intratympanic gentamicin instillation for Meniere's disease. Otol Neurotol. 28:1140–1144. 2007.PubMed/NCBI View Article : Google Scholar
44	Ren H, Yin T, Lu Y, Kong W and Ren J: Intratympanic dexamethasone injections for refractory Meniere' s disease. Int J Clin Exp Med. 8:6016–6023. 2015.PubMed/NCBI
45	Martin-Sanz E, Esteban-Sanchez J, Rodriganez-Riesco L and Sanz-Fernandez R: Transitory effect on endolymphatic hydrops of the intratympanic steroids for Meniere's disease. Laryngoscope. 125:1183–1188. 2015.PubMed/NCBI View Article : Google Scholar
46	Peneda JF, Lima NB, Monteiro F, Silva JV, Gama R and Conde A: Immune-mediated inner ear disease: Diagnostic and therapeutic approaches. Acta Otorrinolaringol Esp. 70:97–104. 2019.PubMed/NCBI View Article : Google Scholar
47	Guo SY, Zhang Y and Liu B: Recent immunology research of Meniere's disease. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 53:953–956. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
48	Ciorba A, Corazzi V, Bianchini C, Aimoni C, Pelucchi S, Skarżyński PH and Hatzopoulos S: Autoimmune inner ear disease (AIED): A diagnostic challenge. Int J Immunopathol Pharmacol. 32(2058738418808680)2018.PubMed/NCBI View Article : Google Scholar
49	Kilpatrick JK, Sismanis A, Spencer RF and Wise CM: Low-dose oral methotrexate management of patients with bilateral Meniere's disease. Ear Nose Throat J. 79:82–83, 86-88, 91-92. 2000.PubMed/NCBI